Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort

Background Different airflow limitation criteria are often used to diagnose COPD. We investigated head-to-head whether Global Initiative for Chronic Obstructive Lung Disease (GOLD) (FEV1/FVC <0.70) and four lower limit of normal (LLN) (FEV1/FVC <LLN) criteria to diagnose airflow limitation differ in identifying individuals at risk of COPD exacerbations and mortality. Methods 108 246 individuals aged 20–100 years randomly selected from the general population were followed from 2003 through 2018 to determine risk of COPD exacerbations, respiratory mortality and all-cause mortality. LLN criteria used equations from Global Lung Initiative (GLI), National Health and Nutrition Examination Survey (NHANES), European Community for Steel and Coal (ECSC) and Copenhagen City Heart Study (CCHS)/Copenhagen General Population Study (CGPS). Results Prevalence of airflow limitation was 17% for GOLD, 8.6% for GLI, 10% for NHANES, 8.2% for ECSC and 14% for CCHS/CGPS. During 14.4 years follow-up, we observed 2745 COPD exacerbations, 762 respiratory deaths and 10 338 all-cause deaths. Comparing individuals with versus without airflow limitation, HRs for COPD exacerbations were 17 (95% CI 14 to 20) for GOLD, 21 (18 to 24) for GLI, 20 (17 to 23) for NHANES, 21 (18 to 24) for ECSC and 18 (16 to 21) for CCHS/CGPS. Corresponding HRs for respiratory mortality were 3.7 (3.1 to 4.3), 6.4 (5.6 to 7.5), 5.7 (4.9 to 6.6), 6.2 (5.3 to 7.2) and 4.5 (3.9 to 5.2), and for all-cause mortality 1.5 (1.4 to 1.5), 1.9 (1.8 to 2.0), 1.8 (1.7 to 1.9), 1.9 (1.8 to 2.0) and 1.7 (1.6 to 1.7), respectively. Differences in Harrell’s C were minute for these outcomes; nonetheless, Harrell’s C was slightly higher for LLN criteria compared with GOLD for mortality outcomes. Conclusions The prevalence of airflow limitation ranged from 8% to 17% using GOLD and four different LLN criteria; however, identified individuals with the five different criteria had similar risk of COPD exacerbations and mortality.

[1]  B. Nordestgaard,et al.  Prevalence, Characteristics, and Prognosis of Early COPD: The Copenhagen General Population Study. , 2019, American journal of respiratory and critical care medicine.

[2]  David Couper,et al.  Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality. , 2019, JAMA.

[3]  J. Vestbo,et al.  Accuracy of Airflow Obstruction Thresholds for Predicting COPD-Related Hospitalization and Mortality: Can Simple Diagnostic Thresholds Be Used for a Complex Disease? , 2019, JAMA.

[4]  A Comparison of Global Lung Initiative 2012 with Third National Health and Nutrition Examination Survey Spirometry Reference Values. Implications in Defining Obstruction , 2019, Annals of the American Thoracic Society.

[5]  J. Soriano,et al.  What is early COPD and why is it important? , 2018, European Respiratory Journal.

[6]  J. Wedzicha,et al.  At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease , 2018, American journal of respiratory and critical care medicine.

[7]  B. Nordestgaard,et al.  Young and middle-aged adults with airflow limitation according to lower limit of normal but not fixed ratio have high morbidity and poor survival: a population-based prospective cohort study , 2018, European Respiratory Journal.

[8]  G. A. Whitmore,et al.  Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction , 2017, American journal of respiratory and critical care medicine.

[9]  B. Nordestgaard,et al.  Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.

[10]  A. Lindberg,et al.  Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis – report from a population-based study , 2017, International journal of chronic obstructive pulmonary disease.

[11]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. , 2017, American journal of respiratory and critical care medicine.

[12]  S. Stanojevic,et al.  Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population , 2016, European Respiratory Journal.

[13]  F. Martinez Early-Life Origins of Chronic Obstructive Pulmonary Disease. , 2016, The New England journal of medicine.

[14]  J. Hankinson,et al.  Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity , 2016, European Respiratory Journal.

[15]  J. Hankinson,et al.  Reference Equations for Spirometry in the Canadian Population. , 2016, Annals of the American Thoracic Society.

[16]  J. Vestbo,et al.  Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. , 2016, The Lancet. Respiratory medicine.

[17]  J. Hallas,et al.  Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition. , 2015, Respiratory medicine.

[18]  P. Burney,et al.  Determinants of underdiagnosis of COPD in national and international surveys. , 2015, Chest.

[19]  S. Rennard,et al.  Early chronic obstructive pulmonary disease: definition, assessment, and prevention , 2015, The Lancet.

[20]  Thierry Troosters,et al.  An official American Thoracic Society/European Respiratory Society statement: research questions in COPD , 2015, European Respiratory Review.

[21]  Dirkje S Postma,et al.  Risk factors and early origins of chronic obstructive pulmonary disease , 2015, The Lancet.

[22]  J. Pretto,et al.  Effects of Adopting the New Global Lung Function Initiative 2012 Reference Equations on the Interpretation of Spirometry , 2013, Respiration.

[23]  J. Vestbo,et al.  Impact of diagnostic criteria on the prevalence of COPD , 2013, The clinical respiratory journal.

[24]  B. Nordestgaard,et al.  New Danish reference values for spirometry , 2013, The clinical respiratory journal.

[25]  J. Pretto,et al.  Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry , 2013, European Respiratory Journal.

[26]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[27]  Stefan Störk,et al.  "GOLD or lower limit of normal definition? a comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study" , 2012, Respiratory Research.

[28]  G. A. Whitmore,et al.  Time course and pattern of COPD exacerbation onset , 2011, Thorax.

[29]  P. Lange,et al.  Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. , 2011, Respiratory medicine.

[30]  J. Lammers,et al.  Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. , 2011, Respiratory medicine.

[31]  S. Salvi,et al.  Chronic obstructive pulmonary disease in non-smokers , 2009, The Lancet.

[32]  T. Seemungal,et al.  COPD exacerbations: defining their cause and prevention , 2007, The Lancet.

[33]  J. Vestbo,et al.  Potential misclassification of causes of death from COPD , 2006, European Respiratory Journal.

[34]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[35]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[36]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[37]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[38]  R. Gill,et al.  Cox's regression model for counting processes: a large sample study : (preprint) , 1982 .